No Data
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Centessa Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 11.56% Morgan Stanley $8 → $11 Maintains Equal-Weight 04/01/2024 52.13% BMO Capital $15 → $15 M
Express News | Centessa Pharmaceuticals, Inc : Morgan Stanley Raises Target Price to $11.00 From $8.00
Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Hold Rating, Raises Target Price to $11
Morgan Stanley analyst Jeffrey Hung maintains $Centessa Pharmaceuticals(CNTA.US)$ with a hold rating, and adjusts the target price from $8 to $11.According to TipRanks data, the analyst has a success
Centessa Pharmaceuticals Plc's (NASDAQ:CNTA) Institutional Investors Lost 12% Over the Past Week but Have Profited From Longer-term Gains
Key Insights Significantly high institutional ownership implies Centessa Pharmaceuticals' stock price is sensitive to their trading actions A total of 8 investors have a majority stake in the compan
Centessa Pharma Hires CFO From Fusion After AstraZeneca Takeover
By Dean Seal Centessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired by AstraZeneca. The clinical-stage pharmaceutical c
Jaguar8 : A big ouch
TrytosaveabitOP Jaguar8: Not as bad as I thought!
Jaguar8 TrytosaveabitOP: CYN was bad haha
TrytosaveabitOP Jaguar8: Yes it was! Hehehe
Jaguar8 TrytosaveabitOP: I’m sure a lot got caught off guard and end up bagholding. Scaling out is key
View more comments...